These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15462323)

  • 1. [Particular features of application of proton pump inhibitors (Rabeprazole) in children with the gastroesophageal reflux disease].
    Khavkin AI; Zhikhareva NS; Rachkova NS; Babaian ML; Volynets GV; Khanakaeva ZK
    Eksp Klin Gastroenterol; 2004; (2):53-6. PubMed ID: 15462323
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assessment of efficacy and safety of two modes of maintenance therapy with rabeprazole in patients with gastroesophageal reflux disease (GERD) of degrees 0 and 1].
    Minushkin ON; Maslovskiĭ LV; Anikina NIu; Shuleshova AG
    Eksp Klin Gastroenterol; 2005; (2):29-35. PubMed ID: 15932152
    [No Abstract]   [Full Text] [Related]  

  • 3. Review article: efficacy and safety of rabeprazole in treating gastroesophageal reflux disease.
    Lim PW; Goh KL
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S61-8. PubMed ID: 15324384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabeprazole experience in Korea; focus on CYP2C19 polymorphism.
    Park SH
    J Gastroenterol Hepatol; 2005 Dec; 20 Suppl():S20-1. PubMed ID: 16359345
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of proton pump inhibitors].
    Herszényi L; Tulassay Z
    Orv Hetil; 2001 Sep; 142(36):1953-61. PubMed ID: 11680100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs.
    Hall J; Dodd S; Durkin M; Sloan S
    Manag Care; 2002 Jul; 11(7 Suppl):14-8. PubMed ID: 12181872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral cavity manifestations of gastroesophageal reflux disease].
    Maev IV; Barer GM; Busarova GA; Pustovoĭt EV; Polikanova EN; Burkov SG; Gurenev GL
    Klin Med (Mosk); 2005; 83(11):33-8. PubMed ID: 16404937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2C19 genotype and the PPIs--focus on rabeprazole.
    Lim PW; Goh KL; Wong BC
    J Gastroenterol Hepatol; 2005 Dec; 20 Suppl():S22-8. PubMed ID: 16359346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors: an update.
    Vanderhoff BT; Tahboub RM
    Am Fam Physician; 2002 Jul; 66(2):273-80. PubMed ID: 12152963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacology and clinical relevance of proton pump inhibitors.
    Katz PO; Frissora C
    Curr Gastroenterol Rep; 2002 Dec; 4(6):459-62. PubMed ID: 12441035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Some comparative aspects of treating the gastroesophageal reflux disease eradication].
    Minushkin ON; Maslovskiĭ LV; Anikina NIu
    Eksp Klin Gastroenterol; 2004; (3):45-8, 104. PubMed ID: 15560401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharma-clinics medication of the month. Rabeprazole (Pariet)].
    Louis E
    Rev Med Liege; 2002 Jan; 57(1):53-6. PubMed ID: 11899500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabeprazole.
    Med Lett Drugs Ther; 1999 Nov; 41(1066):110-2. PubMed ID: 10987010
    [No Abstract]   [Full Text] [Related]  

  • 15. Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment.
    Miner P
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():20-9. PubMed ID: 15496215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor.
    Gardner JD; Sloan S; Robinson M; Miner PB
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1381-6. PubMed ID: 15606401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders.
    Robinson M
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():30-7. PubMed ID: 15496216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proton pump inhibitors: Rabeprazole].
    Yoshino J
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():645-9. PubMed ID: 11979863
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the efficacy of pariet in patients with gastroesophageal reflux disease with thoracic pain not connected with cardiac disease].
    Maev IV; Kucheriavyĭ IuA; Danilin MS
    Eksp Klin Gastroenterol; 2003; (5):10-2, 192. PubMed ID: 14621603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-generation proton pump inhibitors: overcoming the limitations of early-generation agents.
    Robinson M
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S43-7. PubMed ID: 11430508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.